PTC Therapeutics retire l'offre de Translarna après que la FDA signale des preuves faibles | Benzinga France
IBB, IHI, XBI: Gain Exposure to Healthcare with These Specialty Exchange-Traded Funds (ETFs) - TipRanks.com